Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C H Insertion. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN101412738A details a novel iron-catalyzed asymmetric O-H insertion. This technology offers cost-effective, high-enantioselectivity routes for API intermediates.
Patent CN111303006B reveals a safer, cost-effective route for amlodipine intermediates, eliminating hazardous NaH and ensuring stable supply chains for global pharma manufacturers.
Novel water-based method for C-N bond construction eliminates metal catalysts, offering green, scalable routes for pharmaceutical intermediates.
Patent CN110590821B details a safe iridium-catalyzed method using sulfur ylides for alpha-borocarbonyls, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN110981919A details a one-pot C-H activation route for eight-membered palladacycles, offering significant cost reduction in organometallic catalyst manufacturing.
Discover advanced synthesis routes for chiral imidazolidinone derivatives targeting M1 receptors. Enhance safety profiles and reduce manufacturing costs with our scalable processes.
Patent CN111303006A reveals a safer Swern oxidation and C-H insertion route for amlodipine intermediates, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Patent CN115974758A reveals safe iridium-catalyzed synthesis avoiding diazo compounds. Delivers cost reduction in pharmaceutical intermediate manufacturing with superior scalability.
Patent CN116283937B reveals metal-free photocatalytic synthesis for high-purity aromatic secondary amines, offering significant supply chain and cost advantages for pharmaceutical manufacturing.
Patent CN116496189B reveals copper-catalyzed synthesis of N-acyl sulfenamides. Enables efficient asymmetric disulfide production for ADCs and pharmaceutical intermediates with mild conditions.
Novel photochemical SO2 insertion method for 3-methylsulfonyl thioflavonoids. Mild conditions, high yield, oxidant-free process ideal for cost-effective pharmaceutical intermediate manufacturing.
Patent CN113087714B reveals a novel Rh(II)-catalyzed N-H insertion route for axial chiral indolocarbazoles, offering high enantioselectivity and scalable pharmaceutical intermediate manufacturing.
Novel cascade reaction method for high-yield polysubstituted pyrroles. Mild conditions, scalable process for pharmaceutical intermediates.
Patent CN113248480B enables high-yield enantioselective synthesis of pharma intermediates under mild conditions, significantly enhancing supply chain reliability and manufacturing cost efficiency.
Discover how cobalt-catalyzed C-H activation enables cost-effective 1H-indole-2-amide production for MAO-A inhibitors and NMDA antagonists. Reduce supply chain risks with scalable chemistry.
Discover a breakthrough chiral rhodium-catalyzed method for carbon-nitrogen axial chiral indole-naphthol compounds with 96%ee, mild conditions, and high yield. Reduce R&D costs and supply chain risks for your API synthesis.